Home » Stocks » Biomerica

Biomerica, Inc. (BMRA)

Stock Price: $5.64 USD -0.20 (-3.42%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed
Pre-market: $5.65 +0.01 (0.18%) Oct 20, 7:04 AM

Stock Price Chart

Key Info

Market Cap 66.28M
Revenue (ttm) 6.64M
Net Income (ttm) -3.48M
Shares Out 11.75M
EPS (ttm) -0.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $5.64
Previous Close $5.84
Change ($) -0.20
Change (%) -3.42%
Day's Open 5.87
Day's Range 5.51 - 5.99
Day's Volume 236,527
52-Week Range 2.05 - 23.39

More Stats

Market Cap 66.28M
Enterprise Value 60.83M
Earnings Date (est) Jan 20, 2021
Ex-Dividend Date n/a
Shares Outstanding 11.75M
Float 9.04M
EPS (basic) -0.32
EPS (diluted) -0.33
FCF / Share -0.51
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 665,253
Short Ratio 3.35
Short % of Float 7.36%
Beta -0.82
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 9.98
PB Ratio 4.84
Revenue 6.64M
Operating Income -3.55M
Net Income -3.48M
Free Cash Flow -5.96M
Net Cash 5.45M
Net Cash / Share 0.46
Gross Margin 26.83%
Operating Margin -53.43%
Profit Margin -52.40%
FCF Margin -89.69%
ROA -19.62%
ROE -42.98%
ROIC -49.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(112.77% upside)
Current: $5.64
Target: 12.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth28.69%-6.53%-3.93%12.68%3.58%-3.09%-20.89%6.44%-
Gross Profit1.781.291.752.021.521.541.672.432.30
Operating Income-2.40-2.41-1.48-0.95-0.83-0.67-0.450.510.50
Net Income-2.34-2.39-1.47-0.91-1.50-0.33-0.220.540.55
Shares Outstanding10.179.218.578.337.637.557.377.026.89
Earnings Per Share-0.23-0.26-0.17-0.11-0.20-0.04-
EPS Growth--------12.5%-
Operating Cash Flow-4.30-2.24-1.17-0.72-0.21-0.41-0.861.390.15
Capital Expenditures-0.03-0.10-0.13-0.10-0.09-0.01-0.14-0.26-0.16
Free Cash Flow-4.33-2.35-1.30-0.82-0.30-0.41-1.001.14-0.02
Cash & Equivalents8.640.691.201.231.891.091.512.471.08
Total Debt1.57-------0.04
Net Cash / Debt7.070.691.201.231.891.091.512.471.03
Book Value14.213.984.334.495.225.605.915.834.98
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Biomerica, Inc.
Country United States
Employees 65
CEO Zackary S. Irani

Stock Information

Ticker Symbol BMRA
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: BMRA


Biomerica, a biomedical technology company, together with its subsidiaries, develops, patents, manufactures, and markets diagnostic and therapeutic products or detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome (IBS) therapy technology and diagnostic-guided therapy that is designed to allow physicians to identify specific foods that when removed from the patient's diet can alleviate the patient's IBS symptoms; Helicobacter pylori products; and develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.